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ABSTRACT  
Objective: The objective of this research was to estimate the concentrations of N-Acetyl-L-cysteine (NAC) and Ambroxol Hydrochloride (AMB) 
simultaneously, in bulk and combined tablet formulation using a new, simple, precise and accurate absorption correction method using UV 
Spectrophotometer. 
Methods: The concentrations of both the drugs (NAC and AMB) were determined using absorption correction method as; at 244 nm only AMB gave 
substantial absorbance and at 220 nm both NAC and AMB gave absorbance. Distilled water was used as a common solvent for both the drugs and 
the method was developed. Further statistical evaluations were carried out and the method was validated.  
Results: In the range of 3-18 µg/ml for AMB at 244 nm and 20-120 µg/ml for NAC at 220 nm, the Beer’s law was obeyed. Percentage recovery for 
AMB was in the range 100.50-101.10% and for NAC it was 99.85-100.20%. The % RSD values reported were less than 2. The developed method was 
validated and was found to be linear, accurate, precise and also rugged.  
Conclusion: The results obtained clearly demonstrated that the proposed method of analysis was simple, sensitive, accurate, precise, rapid and also 
economical and could be applied successfully for the simultaneous estimation of NAC and AMB in bulk and combined tablet formulation. 
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INTRODUCTION 
N-Acetyl-L-cysteine (NAC), ((2R)-2-(acetylamino)-3-sulfanyl 
propanoic acid), (fig.1) is used in bronchitis, pulmonary diseases and 
other respiratory diseases as a mucolytic agent [1]. 
 
Fig. 1: Chemical structure of N-Acetyl-L-cysteine 
 
It reduces the viscosity of pulmonary secretions by depolymerizing 
the mucopolysaccharides. Along with significant mucolytic effect, it 
also has anti-oxidant and anti-inflammatory effects and also used as 
an antidote in Paracetamol poisoning [2]. As per the recent animal 
and human studies of NAC, it has shown it to be a powerful 
antioxidant and a potential therapeutic agent in the treatment of HIV 
infections, heavy metal toxicity, cancer, heart disease, and other 
diseases characterized by free radical and oxidant damage [3]. A 
number of spectrophotometric [4], colorimetric [5], potentiometric 
[6], chemiluminescence [7], HPLC with electrochemical [8-11], 
fluorimetric [12], mass [13, 14] and ultraviolet [15-17] detectors 
and GC [18] have been widely applied as the main methods of 
detection in biological samples and pharmaceuticals. 
Ambroxol hydrochloride (AMB) is chemical, trans-4-((2-amino-3, 5-
dibromobenzyl) amino) cyclohexanol hydrochloride (fig. 2). AMB 
helps in reducing the bronchial hyper-reactivity and acts as a cough 
suppressant and also mucolytic [19, 20]. 
AMB is a metabolite of bromhexine. It acts an expectorant and 
mucolytic agent which can be used in the treatment of acute and 
chronic disorders related to the production of excess or thick mucus 
[21, 22]. For the determination of AMB, various methods like HPLC 
[23-26], GC [27, 28], LC-MS [29] and Capillary electrophoresis 
[30] are available. 
 
Fig. 2: Chemical structure of Ambroxol Hydrochloride 
 
Both the drugs are official in Indian Pharmacopoeia (IP) and the 
United States Pharmacopoeia (USP). An extensive literature survey 
was performed which revealed that there are no methods reported 
for the assay of NAC and AMB in combined tablet dosage form by UV 
spectrophotometry. Methods are reported for estimation of NAC and 
AMB alone or in combination with other drugs using UV 
Spectrophotometer [31-33]. The study was thus performed with an 
aim to develop a simple, sensitive, precise, rapid, accurate and 
economic method for determination of NAC and AMB in combined 
tablet dosage form. The tablet formulation containing AMB and NAC 
manufactured by Tablets (India) Ltd. named AMBRONAC was used. 
The content of the tablets was 200 mg of NAC (USP) and 30 mg of 
AMB (IP) in each tablet. 
MATERIALS AND METHODS 
Instrumentation 
The present work was carried out on Shimadzu - 1800 double beam 
UV - Visible spectrophotometer which was equipped with a pair of 
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10 mm matched quartz cells. The glass wares used were of ‘A’ grade. 
They were all thoroughly cleaned and rinsed with double distilled 
water and dried in hot air oven prior to the use. The software used 
for UV determination was UV PROBE. 
Reagents and chemicals 
Pure active pharmaceutical ingredients were obtained as a gift 
sample from Kores (India) Pharmaceutical Division Pvt. Ltd., Roha, 
Raigad (AMB) and Pallav Chemicals, Mumbai (NAC). Tablet 
formulation of a combination of the drugs AMB (30 mg) and NAC 
(200 mg) named AMBRONAC, manufactured and marketed by 
tablets (India) Ltd. was obtained. All other chemicals required of 
analytical grade, for the experiment were procured from SD Fine 
Chemicals, Mumbai. 
Experimental conditions 
Distilled water was the solvent used to dissolve both the drugs. 
Thus, all the stock solutions and further all dilutions were prepared 
using distilled water. The analysis was completely carried out in 
controlled conditions of temperature, humidity and pressure. 
Preparation of standard stock solution 
100 mg of NAC and 15 mg of AMB were weighed accurately and 
transferred into a 100 ml volumetric flask. The stock solution was 
prepared by dissolving both the drugs in distilled water by 
sonication technique and then made up to the mark with distilled 
water. The final concentrations obtained, were 1000 µg/ml and 150 
µg/ml for NAC and AMB respectively. 
Spectral studies 
The stock solution of NAC was diluted to make 100 µg/ml solutions 
and AMB to 15 µg/ml. Distilled water was used as a blank, and the 
solutions were scanned in a UV Spectrophotometer in the range of 
200 nm to 400 nm in 1 cm cell. The spectrum so obtained was 
recorded. 
It was observed from the spectrum, that at 244 nm only AMB has 
substantial absorbance, whereas, at 220 nm, both AMB and NAC 
showed substantial absorbance. Thus, estimation of AMB was 
carried at 244 nm without any interference, as NAC has zero 
absorbance at 244 nm. At 220 nm the absorbance of AMB was 
deducted from the total absorbance of the mixture which gave the 
corrected absorbance for NAC.  
The concentrations of the solutions were calculated using the Beer-
Lamberts Law:  
A = a × b × c 
Where, 
‘A’ is the absorbance of the solution, ‘a’ is the absorptivity, ‘b’ is the 
path length and ‘c’ is the concentration.  
Thus, concentration at different wavelengths was found using the 
equation:  
Cx = Ax ÷ ax 
Cy = (Axy − Ax) ÷ ay 
Where, 
Cx is the concentration of the drug ‘x’ at a wavelength, Cy is the 
concentration of the drug ‘y’ at a wavelength, Ax is the absorbance of 
drug ‘x’, Axy is the absorbance of mixture of drugs ‘x and y’, ax is the 
absorptivity of drug ‘x’ at a wavelength, ay is the absorptivity of drug 
‘y’ at a wavelength. 
From the standard stock solutions of AMB and NAC, the aliquots 
were transferred into 10 ml calibrated volumetric flasks and diluted 
using distilled water, to make final concentrations of the range 3 to 
18 µg/ml for AMB and 20 to 120 µg/ml for NAC and the calibration 
curves were obtained at their respective wavelengths, 244 nm and 
220 nm. Also, the calibration curve for AMB was plotted at 220 nm 
for the concentration range 3 to 18 µg/ml.  
Analysis of synthetic mixture of AMB and NAC 
From the stock solutions of AMB and NAC, different mixtures of the 
two drugs were prepared into 10 ml calibrated volumetric flask and 
diluted using distilled water. All the mixtures prepared, were then 
measured for absorbance at wavelengths 244 nm and 220 nm and 
their concentrations were determined using absorbance correction 
method. 
Analysis of tablet formulation 
The average weight of 20 tablets was determined accurately. The 
tablets were powdered into fine particles by triturating them using a 
mortar and pestle. Powder equivalent to 100 mg of NAC was 
weighed accurately and transferred into a 100 ml calibrated 
volumetric flask. A minimum quantity of distilled water was added 
to the volumetric flask to dissolve the powder using sonication for 
about 20 min, after which the volume was made up to the mark 
using the same solvent. The solution was then filtered using a 0.45 µ 
Whatmann filter paper using a vacuum pump. The filtrate in the 
form of a clear solution was then subjected to further dilutions to 
obtain 100 µg/ml solution of NAC and 15 µg/ml solution of AMB 
theoretically. At all the selected wavelengths the absorbance of the 
sample solution was accurately measured. The concentrations of 
AMB and NAC in the tablet formulation were thus calculated. Six 
solutions using the same procedures were analyzed.  
Method validation  
Following were the parameters which were performed in order to 
validate the method-Linearity, Accuracy, Precision, LOD, LOQ, and 
Ruggedness [34]. 
Linearity 
Six different concentrations were checked for linearity by diluting 
the stock solutions. The final concentrations for AMB were in the 
range of 3-18 µg/ml and for NAC in the range 20-120 µg/ml and 
absorbance were measured at wavelengths 244 nm and 220 nm 
respectively. Concentrations of AMB were also measured at 220 nm. 
Calibration curves (n=6) were plotted between the concentration of 
solution and absorbance of drugs.  
Sensitivity 
Sensitivity was checked by determination of limit of detection (LOD) 
and limit of quantification (LOQ) using the following equations for 
six replicates;  
LOD = 3.3σ ÷ s And LOQ = 10σ ÷ s 
Where, 
‘σ’ is the standard deviation of y-intercept of calibration curve and 
‘s’ is the slope of regression equation.  
Precision  
Repeatability and intermediate precision were performed to check 
the precision of the method. Six replicates of the same concentration 
were used for determining the repeatability, and intermediate 
precision was determined by interday and intraday analysis where 
three replicates of same concentration were analyzed on the same 
day and also on successive three days. The quantity of each drug 
present in the tablet formulation was calculated and percentage 
relative standard deviation was also obtained.  
Accuracy  
The recovery studies were carried out to check the interference of 
excipients and other interferences at three different concentrations 
for which standard addition method was used. The percentage 
recovery was calculated from the total amount of the drug found and 
the procedure was repeated three times for all the concentrations. 
Percentage relative standard deviation was also found out.  
Ruggedness  
It is the degree of reproducibility of results obtained after analysis of 
samples at a different place, different time, by different analyst, etc. 
Variations between the conditions and its effect on the results are 
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determined by ruggedness. The determination of AMB and NAC was 
thus carried out using different analyst and using a different instrument. 
Percentage relative standard deviation was then calculated.  
RESULTS AND DISCUSSION 
A rapid, sensitive, precise, accurate and economic analytical method 
has been proposed in the article, for the simultaneous estimation of 
AMB and NAC in pure form and tablet formulation. The method is 
based on absorbance correction where at a certain wavelength only 
one drug possesses absorbance whereas at other wavelength both 
the drugs show substantial absorbance. Simultaneous estimation 
was carried out for AMB and NAC using distilled water at 
wavelengths 220 nm and 244 nm (fig. 3). At 244 nm only AMB 
showed absorbance and thus its concentration was determined 
directly from the absorbance, whereas at 220 nm both AMB and NAC 
showed absorbance. Thus correction of absorbance helps estimate 
the concentration of NAC, the other drug in the combination by 
subtracting the known absorbance of AMB at 220 nm. Solution 
stability was performed at different intervals using the same 
solution, and it was found that the solution is stable up to 6 h. 
In the range of 3-18 µg/ml for AMB at 244 nm and 220 nm and 20-
120 µg/ml for NAC at 220 nm, the Beer’s law was obeyed. The 
absorbances of the drugs were found to be linear with concentration 
as the values for correlation coefficient were above 0.999 at all the 
wavelengths. LOD and LOQ values of 0.3840 µg/ml and 1.16 µg/ml 
were observed for AMB and 1.525 µg/ml and 4.62 µg/ml were 
observed for NAC (table 1). The values indicated that the method is 
sensitive and thus can even be used for determination of drugs even 
with lower concentrations. 
 
 
Fig. 3: Overlain spectrum of NAC and AMB (100 µg/ml and 15 
µg/ml) 
  
Table 1: Data for spectral and linearity characteristics 
Parameters AMB* NAC* 
λmax 244 nm 220 nm 
Linearity Range (µg/ml) 3-18 20-120 
Correlation coefficient (r2) 0.9991 0.9993 
Slope (m) 0.027 0.004 
Intercept (c) 0.003 0.009 
Regression equation (𝑦𝑦 = 𝑚𝑚𝑚𝑚 + 𝑐𝑐) y= 0.027x+0.003 y= 0.004x+0.009 
LOD (µg/ml) 0.3840 1.525 
LOQ (µg/ml) 1.16 4.622 
 *Mean of six observations 
 
Synthetic mixtures of the drugs at various concentrations were 
analyzed to study the mutual interference in the absorbance if any, 
using the proposed method. The % recovery of AMB was 100.33% 
to 101.66% and for NAC it was 98.89% to 101.11% (table 2) which 
indicated that there is no mutual interference between these 
drugs.
  
Table 2: Data of analysis of synthetic mixtures for linearity 
Concentration of AMB (µg/ml) % Recovery 
(AMB) 
Concentration of NAC (µg/ml) % Recovery 
(NAC) Theoretical Experimental* Theoretical Experimental* 
3 3.03 101.23 20 20.22 101.11 
6 6.10 101.66 40 40.13 100.32 
9 9.13 101.44 60 59.78 99.63 
12 12.08 100.66 80 79.63 99.53 
15 15.19 101.26 100 98.89 98.89 
18 18.06 100.33 120 119.23 99.35 
*Mean of three replicates 
 
The label claim present in the tablet formulation was found to be 
101.18±0.1778 for AMB and 98.95±0.1300 for NAC and their % RSD 
were 0.18% and 0.13% respectively (table 3) which indicated that 
the method is precise as the values were in good agreement with the 
label claim. 
The precision of the method was also carried out using intraday and 
interday analysis. The values of % RSD for AMB were 0.29% for 
intraday and 0.85% for inter-day and for NAC they were 0.35% for 
intraday and 0.82% for inter-day analysis which indicated that the 
method is precise. For the estimation of the ruggedness of the 
method, the analysis was performed on different instruments and by 
a different analyst. The values of % RSD were less than 2% (table 
4) which indicated that the method is rugged and can be suitably 
used for estimation of NAC and AMB in combination and 
parameters like the difference in days, instruments or analyst 
won’t affect the method. 
% Recovery studies were performed in order to check the accuracy 
of the method, at three different concentrations at 80%, 100% and 
120% of the standard drugs AMB and NAC. To the pre-analyzed 
sample, the three concentrations were added and analyzed. % 
Recovery for AMB was in the range 100.50-101.10% and for NAC it 
was 99.85-100.20%. The % RSD values obtained were 0.32% and 
0.18% for AMB and NAC respectively (table 5). Lower % RSD values 
indicate that the drugs can be successfully recovered from the 
formulation and estimated. This implies that the method is accurate 
for estimation of NAC and AMB. 
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Table 3: Results of analysis of tablet formulation 
Parameters AMB NAC 
Label claim (mg) 30 200 
% Assay* 101.18 98.95 
SD 0.1778 0.1300 
%RSD 0.18% 0.13% 
*Mean of six determinations 
 
Table 4: Results for intermediate precision and ruggedness of method 
Parameters % Label claim estimated (mean±% RSD) 
AMB NAC 
Intraday precision (n=3) 100.86±0.29 100.07±0.35 
Inter-day precision (n=3) 100.32±0.85 99.993±0.82 
Instrument I (n=3) 100.67±0.33 99.98±0.48 
Instrument II (n=3) 99.93±0.26 100.10±0.52 
Analyst I (n=3) 100.42±0.30 100.03±0.32 
Analyst II (n=3) 100.28±0.21 99.90±0.41 
 n= number of replicates  
 
Table 5: Results of recovery studies 











































*Mean of three observations 
 
The results obtained from above set of observations prove that the 
method is useful in determining the concentration of the drugs from 
the synthetic mixture and tablet formulation. The developed method 
is based on the use of very economical solvent and hence can be 
performed with ease. Simultaneous estimation of the drugs can be 
achieved by various other techniques like simultaneous equation 
method or absorbance ratio method [35], but absorbance correction 
method was found to be most important in the case of drugs which 
show zero absorbance at maximum absorption of another drug. 
Estimation of NAC and AMB thus can be economically and simply 
done by absorption correction method. 
CONCLUSION 
The method was developed and validated which provided an 
inference that the method is sensitive, linear, simple, accurate, 
precise, rugged and also economical. Thus, the proposed method can 
be applied effectively for routine analysis of AMB and NAC bulk 
dosage forms as well as in combined tablet dosage form. 
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